Sphingolipids and membrane biology as determined from genetic models

Prostaglandins and Other Lipid Mediators

Volumn 85, Issue 1-2, 2008, Pages 1-16

  Rao, Raghavendra Pralhada ^a   Acharya, Jairaj K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Animal models; Genetics; Membrane biology; Sphingolipids

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; ALPHA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; CERAMIDE GLUCOSYLTRANSFERASE; GALACTOSYLCERAMIDASE; GLUCOSYLCERAMIDASE; MEMBRANE RECEPTOR; N ACETYLGALACTOSAMINYLTRANSFERASE; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE;

ARABIDOPSIS; BIOINFORMATICS; BIOSYNTHESIS; DROSOPHILA MELANOGASTER; ENDOCYTOSIS; EXOCYTOSIS; FABRY DISEASE; FARBER DISEASE; GAUCHER DISEASE; GENETIC MODEL; GENOMICS; GLOBOID CELL LEUKODYSTROPHY; INBORN ERROR OF METABOLISM; KNOCKOUT MOUSE; LIPID RAFT; LIPIDOSIS; MAMMAL; MEMBRANE BIOLOGY; METACHROMATIC LEUKODYSTROPHY; MOUSE; MUTATION; NIEMANN PICK DISEASE; NONHUMAN; PHENOTYPE; REVIEW; SACCHAROMYCES CEREVISIAE; SANDHOFF DISEASE; SIGNAL TRANSDUCTION; TAY SACHS DISEASE;

ANIMALS; CELL MEMBRANE; ENDOCYTOSIS; EXOCYTOSIS; HUMANS; LIGANDS; MODELS, GENETIC; RECEPTORS, CELL SURFACE; SPHINGOLIPIDS;

EID: 38049092598     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2007.10.002     Document Type: Review

References (209)

1. Adachi-Yamada T., Gotoh T., Sugimura I., et al. De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs. Mol Cell Biol 19 (1999) 7276-7286
2. Hannun Y.A., Luberto C., and Argraves K.M. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40 (2001) 4893-4903
3. Huwiler A., Kolter T., Pfeilschifter J., and Sandhoff K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485 (2000) 63-99
4. Wells G.B., and Lester R.L. The isolation and characterization of a mutant strain of Saccharomyces cerevisiae that requires a long chain base for growth and for synthesis of phosphosphingolipids. J Biol Chem 258 (1983) 10200-10203
5. Kim M.Y., Linardic C., Obeid L., and Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266 (1991) 484-489
6. Morales A., Lee H., Goni F.M., Kolesnick R., and Fernandez-Checa J.C. Sphingolipids and cell death. Apoptosis 12 (2007) 923-939
7. Spiegel S., and Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 277 (2002) 25851-25854
8. Kashiwagi K., Shirai Y., Kuriyama M., Sakai N., and Saito N. Importance of C1B domain for lipid messenger-induced targeting of protein kinase C. J Biol Chem 277 (2002) 18037-18045
9. Hannun Y.A., Loomis C.R., Merrill Jr. A.H., and Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261 (1986) 12604-12609
10. Allen J.A., Halverson-Tamboli R.A., and Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8 (2007) 128-140
11. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14 (1998) 111-136
12. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1 (2000) 31-39
13. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., and Rapoport T.A. Gangliosides are receptors for murine polyoma virus and SV40. Embo J 22 (2003) 4346-4355
14. Low J.A., Magnuson B., Tsai B., and Imperiale M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 80 (2006) 1361-1366
15. Yamashita T., Hashiramoto A., Haluzik M., et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 100 (2003) 3445-3449
16. Holthuis J.C., Pomorski T., Raggers R.J., Sprong H., and Van Meer G. The organizing potential of sphingolipids in intracellular membrane transport. Physiol Rev 81 (2001) 1689-1723
17. Shayman J.A. Sphingolipids. Kidney Int 58 (2000) 11-26
18. Posse de Chaves E.I. Sphingolipids in apoptosis, survival and regeneration in the nervous system. Biochim Biophys Acta 1758 (2006) 1995-2015
19. Chalfant C.E., and Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118 (2005) 4605-4612
20. Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta 1585 (2002) 153-162
21. Spiegel S., and Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4 (2003) 397-407
22. Acharya U., and Acharya J.K. Enzymes of sphingolipid metabolism in Drosophila melanogaster. Cell Mol Life Sci 62 (2005) 128-142
23. Taha T.A., Mullen T.D., and Obeid L.M. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 1758 (2006) 2027-2036
24. Dickson R.C., Sumanasekera C., and Lester R.L. Functions and metabolism of sphingolipids in Saccharomyces cerevisiae. Prog Lipid Res 45 (2006) 447-465
25. Fyrst H., Herr D.R., Harris G.L., and Saba J.D. Characterization of free endogenous C14 and C16 sphingoid bases from Drosophila melanogaster. J Lipid Res 45 (2004) 54-62
26. Merrill Jr. A.H. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 277 (2002) 25843-25846
27. Dickson R.C., and Lester R.L. Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta 1583 (2002) 13-25
28. Hildenbrandt G.R., Abraham T., and Bieber L.L. Metabolism of ceramide phosphorylethanolamine, phosphatidylinositol, phosphatidylserine and phosphatidylglycerol by housefly larvae. Lipids 6 (1971) 508-516
29. Bieber L.L., O'Connor J.D., and Sweeley C.C. The occurrence of tetradecasphing-4-enine and hexadecasphing-4-enine as the principal sphingosines of Musca domestica larvae and adults. Biochim Biophys Acta 187 (1969) 157-159
30. Hanada K. Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol Cell Biochem 286 (2006) 23-31
31. Sims K.J., Spassieva S.D., Voit E.O., and Obeid L.M. Yeast sphingolipid metabolism: clues and connections. Biochem Cell Biol 82 (2004) 45-61
32. Futerman A.H., Stieger B., Hubbard A.L., and Pagano R.E. Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J Biol Chem 265 (1990) 8650-8657
33. Futerman A.H., and Pagano R.E. Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem J 280 Pt 2 (1991) 295-302
34. Jeckel D., Karrenbauer A., Burger K.N., van Meer G., and Wieland F. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol 117 (1992) 259-267
35. Simon Jr. C.G., Holloway P.W., and Gear A.R. Exchange of C(16)-ceramide between phospholipid vesicles. Biochemistry 38 (1999) 14676-14682
36. Funato K., and Riezman H. Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast. J Cell Biol 155 (2001) 949-959
37. Hanada K., Kumagai K., Yasuda S., et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426 (2003) 803-809
38. Kumagai K., Yasuda S., Okemoto K., Nishijima M., Kobayashi S., and Hanada K. CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem 280 (2005) 6488-6495
39. Perry R.J., and Ridgway N.D. Molecular mechanisms and regulation of ceramide transport. Biochim Biophys Acta 1734 (2005) 220-234
40. Dickson R.C., and Lester R.L. Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1438 (1999) 305-321
41. Holthuis J.C., van Meer G., and Huitema K. Lipid microdomains, lipid translocation and the organization of intracellular membrane transport. Mol Membr Biol 20 (2003) 231-241 (Review)
42. D'Hondt K., Heese-Peck A., and Riezman H. Protein and lipid requirements for endocytosis. Annu Rev Genet 34 (2000) 255-295
43. Mellman I. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12 (1996) 575-625
44. Souza C.M., and Pichler H. Lipid requirements for endocytosis in yeast. Biochim Biophys Acta 1771 (2007) 442-454
45. Sutterlin C., Doering T.L., Schimmoller F., Schroder S., and Riezman H. Specific requirements for the ER to Golgi transport of GPI-anchored proteins in yeast. J Cell Sci 110 Pt 21 (1997) 2703-2714
46. Buede R., Rinker-Schaffer C., Pinto W.J., Lester R.L., and Dickson R.C. Cloning and characterization of LCB1, a Saccharomyces gene required for biosynthesis of the long-chain base component of sphingolipids. J Bacteriol 173 (1991) 4325-4332
47. Zanolari B., Friant S., Funato K., Sutterlin C., Stevenson B.J., and Riezman H. Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae. Embo J 19 (2000) 2824-2833
48. Kubler E., and Riezman H. Actin and fimbrin are required for the internalization step of endocytosis in yeast. Embo J 12 (1993) 2855-2862
49. Lamaze C., Fujimoto L.M., Yin H.L., and Schmid S.L. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 272 (1997) 20332-20335
50. Friant S., Zanolari B., and Riezman H. Increased protein kinase or decreased PP2A activity bypasses sphingoid base requirement in endocytosis. Embo J 19 (2000) 2834-2844
51. Friant S., Lombardi R., Schmelzle T., Hall M.N., and Riezman H. Sphingoid base signaling via Pkh kinases is required for endocytosis in yeast. Embo J 20 (2001) 6783-6792
52. Inagaki M., Schmelzle T., Yamaguchi K., Irie K., Hall M.N., and Matsumoto K. PDK1 homologs activate the Pkc1-mitogen-activated protein kinase pathway in yeast. Mol Cell Biol 19 (1999) 8344-8352
53. Zhang X., Lester R.L., and Dickson R.C. Pil1p and Lsp1p negatively regulate the 3-phosphoinositide-dependent protein kinase-like kinase Pkh1p and downstream signaling pathways Pkc1p and Ypk1p. J Biol Chem 279 (2004) 22030-22038
54. Errede B., and Levin D.E. A conserved kinase cascade for MAP kinase activation in yeast. Curr Opin Cell Biol 5 (1993) 254-260
55. Levin D.E. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 69 (2005) 262-291
56. Balguerie A., Bagnat M., Bonneu M., Aigle M., and Breton A.M. Rvs161p and sphingolipids are required for actin repolarization following salt stress. Eukaryot Cell 1 (2002) 1021-1031
57. Acharya U., Patel S., Koundakjian E., Nagashima K., Han X., and Acharya J.K. Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science 299 (2003) 1740-1743
58. Alloway P.G., Howard L., and Dolph P.J. The formation of stable rhodopsin-arrestin complexes induces apoptosis and photoreceptor cell degeneration. Neuron 28 (2000) 129-138
59. Kiselev A., Socolich M., Vinos J., Hardy R.W., Zuker C.S., and Ranganathan R. A molecular pathway for light-dependent photoreceptor apoptosis in Drosophila. Neuron 28 (2000) 139-152
60. Orem N.R., and Dolph P.J. Loss of the phospholipase C gene product induces massive endocytosis of rhodopsin and arrestin in Drosophila photoreceptors. Vision Res 42 (2002) 497-505
61. Kitamoto T. Conditional modification of behavior in Drosophila by targeted expression of a temperature-sensitive shibire allele in defined neurons. J Neurobiol 47 (2001) 81-92
62. Chang H.Y., and Ready D.F. Rescue of photoreceptor degeneration in rhodopsin-null Drosophila mutants by activated Rac1. Science 290 (2000) 1978-1980
63. Acharya U., Mowen M.B., Nagashima K., and Acharya J.K. Ceramidase expression facilitates membrane turnover and endocytosis of rhodopsin in photoreceptors. Proc Natl Acad Sci USA 101 (2004) 1922-1926
64. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., and Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochem J 369 (2003) 199-211
65. Nichols B.J., Ungermann C., Pelham H.R., Wickner W.T., and Haas A. Homotypic vacuolar fusion mediated by t- and v-SNAREs. Nature 387 (1997) 199-202
66. Ferro-Novick S., and Jahn R. Vesicle fusion from yeast to man. Nature 370 (1994) 191-193
67. Burri L., and Lithgow T. A complete set of SNAREs in yeast. Traffic 5 (2004) 45-52
68. Gurunathan S., Chapman-Shimshoni D., Trajkovic S., and Gerst J.E. Yeast exocytic v-SNAREs confer endocytosis. Mol Biol Cell 11 (2000) 3629-3643
69. Gerst J.E., Rodgers L., Riggs M., and Wigler M. SNC1, a yeast homolog of the synaptic vesicle-associated membrane protein/synaptobrevin gene family: genetic interactions with the RAS and CAP genes. Proc Natl Acad Sci USA 89 (1992) 4338-4342
70. Protopopov V., Govindan B., Novick P., and Gerst J.E. Homologs of the synaptobrevin/VAMP family of synaptic vesicle proteins function on the late secretory pathway in S. cerevisiae. Cell 74 (1993) 855-861
71. David D., Sundarababu S., and Gerst J.E. Involvement of long chain fatty acid elongation in the trafficking of secretory vesicles in yeast. J Cell Biol 143 (1998) 1167-1182
72. Marash M., and Gerst J.E. t-SNARE dephosphorylation promotes SNARE assembly and exocytosis in yeast. Embo J 20 (2001) 411-421
73. Grote E., Vlacich G., Pypaert M., and Novick P.J. A snc1 endocytosis mutant: phenotypic analysis and suppression by overproduction of dihydrosphingosine phosphate lyase. Mol Biol Cell 11 (2000) 4051-4065
74. Gerst J.E. Conserved alpha-helical segments on yeast homologs of the synaptobrevin/VAMP family of v-SNAREs mediate exocytic function. J Biol Chem 272 (1997) 16591-16598
75. Herr D.R., Fyrst H., Phan V., et al. Sply regulation of sphingolipid signaling molecules is essential for Drosophila development. Development 130 (2003) 2443-2453
76. Li G., Foote C., Alexander S., and Alexander H. Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. Development 128 (2001) 3473-3483
77. Kumar A., Wessels D., Daniels K.J., Alexander H., Alexander S., and Soll D.R. Sphingosine-1-phosphate plays a role in the suppression of lateral pseudopod formation during Dictyostelium discoideum cell migration and chemotaxis. Cell Motil Cytoskeleton 59 (2004) 227-241
78. Chen W.V., Delrow J., Corrin P.D., Frazier J.P., and Soriano P. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat Genet 36 (2004) 304-312
79. Schmahl J., Raymond C.S., and Soriano P. PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 39 (2007) 52-60
80. Proszynski T.J., Klemm R.W., Gravert M., et al. A genome-wide visual screen reveals a role for sphingolipids and ergosterol in cell surface delivery in yeast. Proc Natl Acad Sci USA 102 (2005) 17981-17986
81. Rohrbough J., Rushton E., Palanker L., et al. Ceramidase regulates synaptic vesicle exocytosis and trafficking. J Neurosci 24 (2004) 7789-7803
82. Yoshimura Y., Okino N., Tani M., and Ito M. Molecular cloning and characterization of a secretory neutral ceramidase of Drosophila melanogaster. J Biochem (Tokyo) 132 (2002) 229-236
83. Ferraretto A., Pitto M., Palestini P., and Masserini M. Lipid domains in the membrane: thermotropic properties of sphingomyelin vesicles containing GM1 ganglioside and cholesterol. Biochemistry 36 (1997) 9232-9236
84. Masserini M., and Ravasi D. Role of sphingolipids in the biogenesis of membrane domains. Biochim Biophys Acta 1532 (2001) 149-161
85. McIntosh T.J., Simon S.A., Needham D., and Huang C.H. Structure and cohesive properties of sphingomyelin/cholesterol bilayers. Biochemistry 31 (1992) 2012-2020
86. Pascher I. Molecular arrangements in sphingolipids. Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability. Biochim Biophys Acta 455 (1976) 433-451
87. Takagi A., Ikeda Y., Takeda E., and Yamamoto A. A newly identified lipoprotein lipase (LPL) gene mutation (F270L) in a Japanese patient with familial LPL deficiency. Biochim Biophys Acta 1502 (2000) 433-446
88. Kojima N., Sakata S., Nakamura S., et al. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis. J Endocrinol Invest 15 (1992) 491-496
89. Spillmann D., and Burger M.M. Carbohydrate-carbohydrate interactions in adhesion. J Cell Biochem 61 (1996) 562-568
90. Brown D. GPI-anchored proteins and detergent-resistant membrane domains. Braz J Med Biol Res 27 (1994) 309-315
91. Jacobson K., Mouritsen O.G., and Anderson R.G. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9 (2007) 7-14
92. Isshiki M., and Anderson R.G. Calcium signal transduction from caveolae. Cell Calcium 26 (1999) 201-208
93. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
94. Smart E.J., Graf G.A., McNiven M.A., et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19 (1999) 7289-7304
95. Bagnat M., Chang A., and Simons K. Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Mol Biol Cell 12 (2001) 4129-4138
96. Lee M.C., Hamamoto S., and Schekman R. Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum. J Biol Chem 277 (2002) 22395-22401
97. Pizzirusso M., and Chang A. Ubiquitin-mediated targeting of a mutant plasma membrane ATPase, Pma1-7, to the endosomal/vacuolar system in yeast. Mol Biol Cell 15 (2004) 2401-2409
98. Wang Q., and Chang A. Sphingoid base synthesis is required for oligomerization and cell surface stability of the yeast plasma membrane ATPase, Pma1. Proc Natl Acad Sci USA 99 (2002) 12853-12858
99. Watanabe R., Funato K., Venkataraman K., Futerman A.H., and Riezman H. Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast. J Biol Chem 277 (2002) 49538-49544
100. Mukhopadhyay K., Prasad T., Saini P., Pucadyil T.J., Chattopadhyay A., and Prasad R. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother 48 (2004) 1778-1787
101. Pasrija R., Prasad T., and Prasad R. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans. Biochem Soc Trans 33 (2005) 1219-1223
102. Sanglard D., Kuchler K., Ischer F., Pagani J.L., Monod M., and Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39 (1995) 2378-2386
103. Prasad R., De Wergifosse P., Goffeau A., and Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27 (1995) 320-329
104. Zhang K., Showalter M., Revollo J., Hsu F.F., Turk J., and Beverley S.M. Sphingolipids are essential for differentiation but not growth in Leishmania. Embo J 22 (2003) 6016-6026
105. Denny P.W., Goulding D., Ferguson M.A., and Smith D.F. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Mol Microbiol 52 (2004) 313-327
106. Schuck S., Honsho M., Ekroos K., Shevchenko A., and Simons K. Resistance of cell membranes to different detergents. Proc Natl Acad Sci USA 100 (2003) 5795-5800
107. Munro S. Lipid rafts: elusive or illusive?. Cell 115 (2003) 377-388
108. Giusto N.M., Roque M.E., and Ilincheta de Boschero M.G. Effects of aging on the content, composition and synthesis of sphingomyelin in the central nervous system. Lipids 27 (1992) 835-839
109. Lightle S.A., Oakley J.I., and Nikolova-Karakashian M.N. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech Ageing Dev 120 (2000) 111-125
110. Tacconi M.T., Lligona L., Salmona M., Pitsikas N., and Algeri S. Aging and food restriction: effect on lipids of cerebral cortex. Neurobiol Aging 12 (1991) 55-59
111. Rao R.P., Yuan C., Allegood J.C., et al. Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci USA 104 (2007) 11364-11369
112. Fukasawa M., Nishijima M., and Hanada K. Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J Cell Biol 144 (1999) 673-685
113. Fukasawa M., Nishijima M., Itabe H., Takano T., and Hanada K. Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-beta -cyclodextrin. J Biol Chem 275 (2000) 34028-34034
114. Funakoshi T., Yasuda S., Fukasawa M., Nishijima M., and Hanada K. Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J Biol Chem 275 (2000) 29938-29945
115. Acharya U., Edwards M.B., Jorquera R.A., et al. Drosophila melanogaster Scramblases modulate synaptic transmission. J Cell Biol 173 (2006) 69-82
116. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed. (1999), Oxford University Press, Oxford, New York
117. Koike T., Ishida G., Taniguchi M., et al. Decreased membrane fluidity and unsaturated fatty acids in Niemann-Pick disease type C fibroblasts. Biochim Biophys Acta 1406 (1998) 327-335
118. Brasitus T.A., and Schachter D. Lipid dynamics and lipid-protein interactions in rat enterocyte basolateral and microvillus membranes. Biochemistry 19 (1980) 2763-2769
119. Stubbs C.D., Ketterer B., and Hicks R.M. The isolation and analysis of the luminal plasma membrane of calf urinary bladder epithelium. Biochim Biophys Acta 558 (1979) 58-72
120. Sillence D.J., and Platt F.M. Glycosphingolipids in endocytic membrane transport. Semin Cell Dev Biol 15 (2004) 409-416
121. Sillence D.J., and Platt F.M. Introduction: glycosphingolipids in cell biology and disease. Semin Cell Dev Biol 15 (2004) 371-373
122. van Meer G., and Sprong H. Membrane lipids and vesicular traffic. Curr Opin Cell Biol 16 (2004) 373-378
123. Kasahara K., Watanabe K., Takeuchi K., et al. Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts. J Biol Chem 275 (2000) 34701-34709
124. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265 (1990) 18713-18716
125. Kawai H., Allende M.L., Wada R., et al. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276 (2001) 6885-6888
126. Coetzee T., Fujita N., Dupree J., et al. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86 (1996) 209-219
127. Flesch F.M., and Gadella B.M. Dynamics of the mammalian sperm plasma membrane in the process of fertilization. Biochim Biophys Acta 1469 (2000) 197-235
128. Alonso T.S., Bonini de Romanelli I.C., Pechen de D'Angelo A.M., and Bazan N.G. Dynamics of cellular membranes during amphibian fertilization and early development. Prog Clin Biol Res 112 Pt B (1982) 55-62
129. Butler A., He X., Gordon R.E., Wu H.S., Gatt S., and Schuchman E.H. Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient mice. Am J Pathol 161 (2002) 1061-1075
130. Butler A., Gordon R.E., Gatt S., and Schuchman E.H. Sperm abnormalities in heterozygous acid sphingomyelinase knockout mice reveal a novel approach for the prevention of genetic diseases. Am J Pathol (2007)
131. Suzuki K., and Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci USA 66 (1970) 302-309
132. Kolter T., and Sandhoff K. Sphingolipid metabolism diseases. Biochim Biophys Acta 1758 (2006) 2057-2079
133. Luddi A., Strazza M., Carbone M., Moretti E., and Costantino-Ceccarini E. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy. Exp Cell Res 304 (2005) 59-68
134. Park J.H., and Schuchman E.H. Acid ceramidase and human disease. Biochim Biophys Acta 1758 (2006) 2133-2138
135. Murase T., Imaeda N., Kondoh N., and Tsubota T. Ceramide enhances acrosomal exocytosis triggered by calcium and the calcium ionophore A23187 in boar spermatozoa. J Reprod Dev 50 (2004) 667-674
136. Fujimoto H., Tadano-Aritomi K., Tokumasu A., et al. Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: ceramide galactosyltransferase-deficient mice. J Biol Chem 275 (2000) 22623-22626
137. Kohyama-Koganeya A., Sasamura T., Oshima E., et al. Drosophila glucosylceramide synthase: a negative regulator of cell death mediated by proapoptotic factors. J Biol Chem 279 (2004) 35995-36002
138. Wandall H.H., Pizette S., Pedersen J.W., et al. Egghead and brainiac are essential for glycosphingolipid biosynthesis in vivo. J Biol Chem 280 (2005) 4858-4863
139. Muller R., Altmann F., Zhou D., and Hennet T. The Drosophila melanogaster brainiac protein is a glycolipid-specific beta 1,3-N-acetylglucosaminyltransferase. J Biol Chem 277 (2002) 32417-32420
140. Goode S., Melnick M., Chou T.B., and Perrimon N. The neurogenic genes egghead and brainiac define a novel signaling pathway essential for epithelial morphogenesis during Drosophila oogenesis. Development 122 (1996) 3863-3879
141. Goode S., Wright D., and Mahowald A.P. The neurogenic locus brainiac cooperates with the Drosophila EGF receptor to establish the ovarian follicle and to determine its dorsal-ventral polarity. Development 116 (1992) 177-192
142. Haines N., and Irvine K.D. Functional analysis of Drosophila beta1,4-N-acetlygalactosaminyltransferases. Glycobiology 15 (2005) 335-346
143. Haines N., and Stewart B.A. Functional roles for beta1,4-N-acetlygalactosaminyltransferase-A in Drosophila larval neurons and muscles. Genetics 175 (2007) 671-679
144. Chen Y.W., Pedersen J.W., Wandall H.H., et al. Glycosphingolipids with extended sugar chain have specialized functions in development and behavior of Drosophila. Dev Biol 306 (2007) 736-749
145. Pappu R., Schwab S.R., Cornelissen I., et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316 (2007) 295-298
146. Hla T. Sphingosine 1-phosphate receptors. Prostaglandins Other Lipid Mediat 64 (2001) 135-142
147. Olivera A., Kohama T., Tu Z., Milstien S., and Spiegel S. Purification and characterization of rat kidney sphingosine kinase. J Biol Chem 273 (1998) 12576-12583
148. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., and Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273 (1998) 23722-23728
149. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 115 (2007) 84-105
150. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15 (2004) 513-520
151. Hla T., and Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 265 (1990) 9308-9313
152. Ancellin N., and Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274 (1999) 18997-19002
153. Lee M.J., Van Brocklyn J.R., Thangada S., et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279 (1998) 1552-1555
154. Van Brocklyn J.R., Lee M.J., Menzeleev R., et al. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 142 (1998) 229-240
155. 2+ homeostasis. Biochem Biophys Res Commun 353 (2007) 268-274
156. Sanchez T., and Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem 92 (2004) 913-922
157. Kluk M.J., and Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta 1582 (2002) 72-80
158. Graler M.H., Bernhardt G., and Lipp M. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics 53 (1998) 164-169
159. Van Brocklyn J.R., Tu Z., Edsall L.C., Schmidt R.R., and Spiegel S. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem 274 (1999) 4626-4632
160. Graler M.H., Grosse R., Kusch A., Kremmer E., Gudermann T., and Lipp M. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J Cell Biochem 89 (2003) 507-519
161. Im D.S., Heise C.E., Ancellin N., et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem 275 (2000) 14281-14286
162. Van Brocklyn J.R., Graler M.H., Bernhardt G., Hobson J.P., Lipp M., and Spiegel S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 95 (2000) 2624-2629
163. Windh R.T., Lee M.J., Hla T., An S., Barr A.J., and Manning D.R. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J Biol Chem 274 (1999) 27351-27358
164. Paik J.H., Skoura A., Chae S.S., et al. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev 18 (2004) 2392-2403
165. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., and Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25 (2005) 11113-11121
166. Sato K., Tomura H., Igarashi Y., Ui M., and Okajima F. Exogenous sphingosine 1-phosphate induces neurite retraction possibly through a cell surface receptor in PC12 cells. Biochem Biophys Res Commun 240 (1997) 329-334
167. Rouach N., Pebay A., Meme W., et al. S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK. Eur J Neurosci 23 (2006) 1453-1464
168. Lee M.J., Thangada S., Claffey K.P., et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99 (1999) 301-312
169. Okamoto H., Takuwa N., Yokomizo T., et al. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 20 (2000) 9247-9261
170. Paik J.H., Chae S., Lee M.J., Thangada S., and Hla T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 276 (2001) 11830-11837
171. Singleton P.A., Dudek S.M., Chiang E.T., and Garcia J.G. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 19 (2005) 1646-1656
172. Allende M.L., and Proia R.L. Sphingosine-1-phosphate receptors and the development of the vascular system. Biochim Biophys Acta 1582 (2002) 222-227
173. Saba J.D., and Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 94 (2004) 724-734
174. Liu Y., Wada R., Yamashita T., et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106 (2000) 951-961
175. McVerry B.J., and Garcia J.G. Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem 92 (2004) 1075-1085
176. Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
177. Allende M.L., Dreier J.L., Mandala S., and Proia R.L. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 279 (2004) 15396-15401
178. Watterson K.R., Ratz P.H., and Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal 17 (2005) 289-298
179. Oskeritzian C.A., Milstien S., and Spiegel S. Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis. Pharmacol Ther (2007)
180. MacLennan A.J., Carney P.R., Zhu W.J., et al. An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci 14 (2001) 203-209
181. Kupperman E., An S., Osborne N., Waldron S., and Stainier D.Y. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 406 (2000) 192-195
182. Sanna M.G., Wang S.K., Gonzalez-Cabrera P.J., et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol 2 (2006) 434-441
183. Gon Y., Wood M.R., Kiosses W.B., et al. S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc Natl Acad Sci USA 102 (2005) 9270-9275
184. Forrest M., Sun S.Y., Hajdu R., et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther 309 (2004) 758-768
185. Kono M., Mi Y., Liu Y., et al. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem 279 (2004) 29367-29373
186. Allende M.L., Sasaki T., Kawai H., et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 279 (2004) 52487-52492
187. Michaud J., Kohno M., Proia R.L., and Hla T. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett 580 (2006) 4607-4612
188. Kharel Y., Lee S., Snyder A.H., et al. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem 280 (2005) 36865-36872
189. Zemann B., Kinzel B., Muller M., et al. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107 (2006) 1454-1458
190. Olivera A., Mizugishi K., Tikhonova A., et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26 (2007) 287-297
191. Tybulewicz V.L., Tremblay M.L., LaMarca M.E., et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357 (1992) 407-410
192. Miklyaeva E.I., Dong W., Bureau A., et al. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. Brain Res 1001 (2004) 37-50
193. Sango K., Yamanaka S., Hoffmann A., et al. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11 (1995) 170-176
194. Ohshima T., Murray G.J., Swaim W.D., et al. alpha-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci USA 94 (1997) 2540-2544
195. Ohshima T., Schiffmann R., Murray G.J., et al. Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice. Proc Natl Acad Sci USA 96 (1999) 6423-6427
196. Ezoe T., Vanier M.T., Oya Y., et al. Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide. J Neurosci Res 59 (2000) 170-178
197. Eliyahu E., Park J.H., Shtraizent N., He X., and Schuchman E.H. Acid ceramidase is a novel factor required for early embryo survival. FASEB J 21 (2007) 1403-1409
198. Li C.M., Park J.H., Simonaro C.M., et al. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics 79 (2002) 218-224
199. Hess B., Saftig P., Hartmann D., et al. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci USA 93 (1996) 14821-14826
200. Lutjohann D., Harzer K., Gieselmann V., and Eckhardt M. Reduced brain cholesterol content in arylsulfatase A-deficient mice. Biochem Biophys Res Commun 344 (2006) 647-650
201. Otterbach B., and Stoffel W. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81 (1995) 1053-1061
202. Pentchev P.G., Gal A.E., Booth A.D., et al. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Biochim Biophys Acta 619 (1980) 669-679
203. Kono M., Dreier J.L., Ellis J.M., et al. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. J Biol Chem 281 (2006) 7324-7331
204. Fujita N., Suzuki K., Vanier M.T., et al. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet 5 (1996) 711-725
205. Matsuda J., Vanier M.T., Saito Y., Tohyama J., Suzuki K., and Suzuki K. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. Hum Mol Genet 10 (2001) 1191-1199
206. Sun Y., Witte D.P., Zamzow M., et al. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking. Hum Mol Genet 16 (2007) 957-971
207. Jennemann R., Sandhoff R., Wang S., et al. Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci USA 102 (2005) 12459-12464
208. Sheikh K.A., Sun J., Liu Y., et al. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96 (1999) 7532-7537
209. Yamashita T., Wada R., Sasaki T., et al. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA 96 (1999) 9142-9147